Trending News

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

Supreme Court Eliminates Heightened Discrimination Standard Under Title VII

Cleaning the Cupboard—Six More Decisions in One Day, and a Largely Harmonious Court - SCOTUS Today

U.S. Supreme Court Holds Majority-Group Plaintiffs Are Not Subject to a Heightened Evidentiary Standard Under Title VII

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

IMUNON Announces Withdrawal of Form S-1 Registration Statement
Posted On Thursday, May 22, 2025
Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel
Posted On Thursday, May 22, 2025
Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025
Posted On Thursday, May 22, 2025
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
Posted On Thursday, May 22, 2025
Actuate Therapeutics Announces Details for 2025 ASCO Annual Meeting Presentation on Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer
Posted On Thursday, May 22, 2025
Candel Therapeutics Presents Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
Posted On Thursday, May 22, 2025
Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting
Posted On Thursday, May 22, 2025
Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences
Posted On Thursday, May 22, 2025
Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in Earlier Lines of Treatment for Relapsed/Refractory Multiple Myeloma
Posted On Thursday, May 22, 2025
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
Posted On Thursday, May 22, 2025
Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors
Posted On Thursday, May 22, 2025
Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025
Posted On Thursday, May 22, 2025
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting
Posted On Thursday, May 22, 2025
Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors
Posted On Thursday, May 22, 2025
Senti Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
Posted On Thursday, May 22, 2025
Bio Usawa and Pacific Environmental Technologies Announce Landmark Partnership to Develop and Deploy Modular cGMP Biomanufacturing Units for Africa
Posted On Thursday, May 22, 2025
Amphista Therapeutics showcases cryo-EM enabled platform for discovering novel Targeted Glue™ degraders at SLAS Europe 2025
Posted On Thursday, May 22, 2025
Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
Posted On Thursday, May 22, 2025
Replimune Reports Fiscal Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Posted On Thursday, May 22, 2025
Sionna Therapeutics to Present Preclinical Data During Oral Session at the 48th European Cystic Fibrosis Conference
Posted On Thursday, May 22, 2025
Tilray Medical Brings Canada’s Iconic Cannabis Brand Good Supply to Germany
Posted On Thursday, May 22, 2025
Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes
Posted On Thursday, May 22, 2025
Foghorn Therapeutics to Participate in Four Upcoming Investor Conferences
Posted On Thursday, May 22, 2025
Skye Bioscience to Participate in Upcoming Investment Conferences
Posted On Thursday, May 22, 2025
Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase
Posted On Thursday, May 22, 2025

Print